Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
- PMID: 9710115
- DOI: 10.1161/01.res.83.3.233
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
Abstract
Angiopoietin-1 (Ang1) has been recently identified as the major physiological ligand for the tyrosine kinase receptor Tie2 and assigned responsibility for recruiting and sustaining periendothelial support cells. Angiopoietin-2 (Ang2) was found to disrupt blood vessel formation in the developing embryo by antagonizing the effects of Ang1 and Tie2 and was thus considered to represent a natural Ang1/Tie2 inhibitor. In vivo effects of either angiopoietin on postnatal neovascularization, however, have not been previously described. Accordingly, we used the cornea micropocket assay of neovascularization to investigate the impact of angiopoietins on neovascularization in vivo. Neither Ang1 nor Ang2 alone promoted neovascularization. Pellets containing vascular endothelial growth factor (VEGF) alone induced corneal neovascularity extending from the limbus across the cornea. Addition of Ang 1 to VEGF (Ang1+VEGF) produced an increase in macroscopically evident perfusion of the corneal neovasculature without affecting macroscopic measurements of length (0.58+/-0.03 mm) or circumferential neovascularity (136+/-10 degrees). In contrast, pellets containing Ang2+VEGF promoted significantly longer (0.67+/-0.05 mm) and more circumferential (160+/-15degrees) neovascularity than VEGF alone or Ang1+VEGF (P<0.05). Excess soluble Tie2 receptor (sTie2-Fc) precluded modulation of VEGF-induced neovascularization by both Ang2 and Ang1. Fluorescent microscopic findings demonstrated enhanced capillary density (fluorescence intensity, 2.55+/-0.23 e+9 versus 1.23+/-0.17 e+9, P<0.01) and increased luminal diameter of the basal limbus artery (39.0+/-2.8 versus 27.9+/-1.3 microm, P<0.01) for Ang1+VEGF compared with VEGF alone. In contrast to Ang1+VEGF, Ang2+VEGF produced longer vessels and, at the tip of the developing capillaries, frequent isolated sprouting cells. In the case of Ang2+VEGF, however, luminal diameter of the basal limbus artery was not increased (26.7+/-1.9 versus 27.9+/-1.3, P=NS). These findings constitute what is to our knowledge the first direct demonstration of postnatal bioactivity associated with either angiopoietin. In particular, these results indicate that angiopoietins may potentiate the effects of other angiogenic cytokines. Moreover, these findings provide in vivo evidence that Ang1 promotes vascular network maturation, whereas Ang2 works to initiate neovascularization.
Comment in
-
Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel.Circ Res. 1998 Aug 10;83(3):342-3. doi: 10.1161/01.res.83.3.342. Circ Res. 1998. PMID: 9710128 No abstract available.
Similar articles
-
Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.Circ Res. 2001 Jan 19;88(1):22-9. doi: 10.1161/01.res.88.1.22. Circ Res. 2001. Retraction in: Circ Res. 2013 Jun 7;112(12):e180. doi: 10.1161/RES.0b013e31829b5cca. PMID: 11139469 Retracted.
-
Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.Invest Ophthalmol Vis Sci. 1999 Aug;40(9):1912-20. Invest Ophthalmol Vis Sci. 1999. PMID: 10440243
-
Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.Invest Ophthalmol Vis Sci. 2003 Jan;44(1):393-402. doi: 10.1167/iovs.02-0276. Invest Ophthalmol Vis Sci. 2003. PMID: 12506101
-
Angiopoietins: vascular growth factors looking for roles in glomeruli.Curr Opin Nephrol Hypertens. 2010 Jan;19(1):20-5. doi: 10.1097/MNH.0b013e328333025e. Curr Opin Nephrol Hypertens. 2010. PMID: 19838115 Review.
-
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.Cells. 2019 May 17;8(5):471. doi: 10.3390/cells8050471. Cells. 2019. PMID: 31108880 Free PMC article. Review.
Cited by
-
Beyond VEGF: Angiopoietin-Tie Signaling Pathway in Diabetic Retinopathy.J Clin Med. 2024 May 9;13(10):2778. doi: 10.3390/jcm13102778. J Clin Med. 2024. PMID: 38792322 Free PMC article. Review.
-
Differential expression of angiogenesis-related genes 'VEGF' and 'angiopoietin-1' in metastatic and EMAST-positive colorectal cancer patients.Sci Rep. 2024 May 8;14(1):10539. doi: 10.1038/s41598-024-61000-x. Sci Rep. 2024. PMID: 38719941 Free PMC article.
-
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment.Brain Tumor Pathol. 2024 Apr;41(2):61-72. doi: 10.1007/s10014-024-00481-0. Epub 2024 Apr 15. Brain Tumor Pathol. 2024. PMID: 38619734 Free PMC article.
-
Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response-a scoping review.BMJ Open Ophthalmol. 2024 Feb 10;9(1):e001516. doi: 10.1136/bmjophth-2023-001516. BMJ Open Ophthalmol. 2024. PMID: 38341189 Free PMC article. Review.
-
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI304-SI312. doi: 10.1093/rheumatology/kead502. Rheumatology (Oxford). 2023. PMID: 37871914 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous